Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases

Digestive and Liver Disease

Volumn 35, Issue 12, 2003, Pages 862-868

  Saibeni, S ^a   Folli, C ^a   de Franchis, R ^a   Borsi, G ^a   Vecchi, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

ASCA; Inflammatory bowel diseases; p ANCA

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY; ANTIIDIOTYPIC ANTIBODY; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; FUNGUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; ITALY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; SACCHAROMYCES CEREVISIAE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SOUTHERN EUROPE; ULCERATIVE COLITIS; BLOOD; COMPARATIVE STUDY; EVALUATION; IMMUNOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; SEROLOGY; STATISTICS;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; STATISTICS;

EID: 1842482789     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2003.07.001     Document Type: Article

References (44)

1. Main J, McKenzie H, Yeaman G, Kerr M, Robson D, Pennington C, et al. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. Br Med J 1988;297:1105.
2. Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 1998;9:1306.
3. Lindberg E, Magnusson KE, Tysk C, Jarnerot G. Antibody (IgG, IgA and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut 1992;33:909.
4. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202.
5. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657.
6. Barnes RMR, Allan S, Taylor-Robinson CH, Finn R, Johnson PM. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol 1990;92:9-15.
7. Gionchetti P, Vecchi M, Rizzello F, Ferretti M, Calabresi C, Venturi A, et al. Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils. Gut 1997;40:102.
8. Roozendaal A, Kallenberg CGM. Are anti-neutrophil cytoplasmic antiodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? Clin Exp Immunol 1999;116:206.
9. Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992;33:1071.
10. Targan SR. The utility of ANCA and ASCA in inflammatory bowel disease. Inflamm Bowel Dis 1999;5:61.
11. Radford-Smith GL, Bansal A. The significance of p-ANCA in inflammatory bowel disease. J Gastroenterol Hepatol 1998;13:863.
12. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
13. Panaccione R, Sandborn WJ. Is antibody testing for inflammatory bowel disease clinically useful? Gastroenterology 1999;116:1001-3.
14. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EJ. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9.
15. Rutgeerts P, Vermeire S. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology 1998;115:1006-9.
16. MacDermott RP. Lack of current clinical value of serological testing in the evaluation of patients with IBD. Inflamm Bowel Dis 1999;5:64-5.
17. Peeters M, Joossens S, Vermeire S, Vlietnick R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4.
18. Sandborn WJ, Loftus Jr EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2001;7:192-201.
19. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, et al. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:449-54.
20. Bartunkova J, Kolarova I, Sediva A, Holzelova E. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Clin Immunol 2002;102:162-8.
21. Lerner A, Shoenfeld Y. Serological markers in inflammatory bowel disease: the pros and cons. Eur J Gastroenterol Hepatol 2002;14:103-5.
22. Linskens RK, Mallant-Hent RC, Groothuismink ZM, Bakker-Jonges LE, Van de Merwe JP, Hooijkaas H, et al. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: p-ANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Eur J Gastroenterol Hepatol 2002;14:1013-8.
23. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000;47:487-96.
24. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996;71:431-6.
25. Lindgren S, Floren CH, Lindhagen T, Starck M, Stewenius J, Nassbergerl V. Low prevalence of antineutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur. J. Gastroenterol. Hepatol. 1995;563-8.
26. Vecchi M, Gionchetti P, Bianchi MB, Belluzzi A, Meucci GM, Campieri M, et al. p-ANCA and development of pouchitis in ulcerative colitis after proctocolectomy and ileoanal pouch anastomosis. Lancet 1994;344:886-7.
27. Sandborn WJ, Landers WJ, Tremaine WJ, Targan SR. Antineutrophil cyoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995;90:740-7.
28. Ferry GD. The use of antineutrophil cytoplasmic antibodies to determine clinical patterns of ulcerative colitis in children. J Pediatr Gastroenterol Nutr 1998;26:475-7.
29. Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, et al. Perinuclear cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996;110:1810-9.
30. Podolsky D. Inflammatory bowel disease. N Engl J Med 2002;347: 417-29.
31. Best WR, Becktel JM, Singleton JW, Kern Jr F. Development of a Crohn's disease activity index. Gastroenterology 1976;70:439-44.
32. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report of a therapeutic trial. Br Med J 1955;2:1041-8.
33. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998,. Inflamm Bowel Dis 2000;6:8-15.
34. Present DH, Banks PA. The role of pANCA and ASCA in differentiating ulcerative colitis, Crohn's disease and indeterminate colitis. Inflamm Bowel Dis 1999;5:66-7.
35. Vermeire S, Joosens S, Peeters M, Monsuur F, Marien G, Bossuyt X, et al. Comparative study of ASCA (Anti-Saccharomyces cerevisiae) assays in inflammatory bowel disease. Gastroenterology 2001;120:827-33.
36. Garcia-Herola A, Nos P, Hoyos M, Hinojosa J, Moles JR, Pascual S, et al. Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease. Gastroenterol Hepatol 1998;21:169-73.
37. Colombel JF, Reumaux D, Duthilleul P, Noel LH, Gower-Rousseau C, Paris JC, et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992;16:656-60.
38. Castellino F, Rosina F, Bansi DS, Bauducci M, Touscoz GA, Giorda L, et al. Antineutrophil cytoplasmic antibodies in inflammatory bowel diseases: do they recognize different subsets of a heterogeneous disease? Eur J Gastroenterol Hepatol 1995;7:859-64.
39. Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G, Torgano G, et al. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity. Digestion 1994;55:34-9.
40. Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001;96:758-65.
41. Sostegni R, Daperno M, Ercole E, Rigazio C, Presso F, Masoero G, et al. Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker? Dig Liver Dis 2001;33:755-61.
42. Perri F, Annese V, Piepoli A, Napolitano G, Lombardi G, Ciavarella G, et al. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol 1998;30:56-61.
43. Jossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002;122:1242-7.
44. Abreu MT. Controversies in IBD. Serologic tests are helpful in managing inflammatory bowel disease. Inflamm Bowel Dis 2002;8: 224-6.